Pharmacological Activation/Inhibition of the Cannabinoid System Affects Alcohol Withdrawal-Induced Neuronal Hypersensitivity to Excitotoxic Insults

Blockade of the Cannabinoid CB1 Receptor and Alcohol Dependence: Preclinical Evidence and Preliminary Clinical Data

(2012) Paola Maccioni et al.   CNS & Neurological Disorders-Drug Targets

Modulation of the endocannabinoid system: Neuroprotection or neurotoxicity?

(2010) Christopher J. Fowler et al.   EXPERIMENTAL NEUROLOGY

Biochemical and Neurotransmitter Changes Implicated in Alcohol-Induced Brain Damage in Chronic or 'Binge Drinking' Alcohol Abuse

(2009) R. J. Ward et al.   ALCOHOL AND ALCOHOLISM

The Neuropathology of Alcohol-Related Brain Damage

(2009) C. Harper   ALCOHOL AND ALCOHOLISM

The endocannabinoid system as a target for the treatment of motor dysfunction

(2009) Javier Fernández-Ruiz   BRITISH JOURNAL OF PHARMACOLOGY

Signaling Pathways from Cannabinoid Receptor-1 Activation to Inhibition of N-Methyl-D-Aspartic Acid Mediated Calcium Influx and Neurotoxicity in Dorsal Root Ganglion Neurons

(2009) Q. Liu et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides

(2009) K. Yaragudri Vinod et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers

(2009) David Ted George et al.   PSYCHOPHARMACOLOGY

Cannabinoid Receptor 1 Blocker Rimonabant (SR 141716) for Treatment of Alcohol Dependence

(2008) Michael Soyka et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The alcohol withdrawal syndrome

(2007) A McKeon et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY